117 Clinical Molecular Genetics providers practice across all 50 states and Washington DC, and 12% received drug or device company payments in 2025. California has the most at 25. Listings are drawn from federal public records and are not endorsements.
| State | Providers | Received payments |
|---|---|---|
| Clinical Molecular Genetics in California | 25 | 0% |
| Clinical Molecular Genetics in New York | 14 | not reported |
| Clinical Molecular Genetics in Massachusetts | 14 | not reported |
| Clinical Molecular Genetics in Texas | 9 | not reported |
| Clinical Molecular Genetics in Washington | 9 | not reported |
| Clinical Molecular Genetics in Florida | 6 | not reported |
| Clinical Molecular Genetics in North Carolina | 5 | not reported |
| Clinical Molecular Genetics in Colorado | 5 | not reported |
| Clinical Molecular Genetics in Ohio | 5 | not reported |
| Clinical Molecular Genetics in New Jersey | 4 | not reported |
| Clinical Molecular Genetics in Tennessee | 4 | not reported |
| Clinical Molecular Genetics in Utah | 4 | not reported |
| Clinical Molecular Genetics in Indiana | 4 | not reported |
| Clinical Molecular Genetics in South Carolina | 3 | not reported |
| Clinical Molecular Genetics in Oregon | 3 | not reported |
| Clinical Molecular Genetics in Pennsylvania | 3 | not reported |
There are 117 Clinical Molecular Genetics providers with active NPI records across all 50 states and Washington DC, according to federal NPPES data refreshed monthly. California has the most at 25.
14 of 117 Clinical Molecular Genetics providers nationally (12%) received at least one payment from a drug or device company in 2025, according to the federal Open Payments program.
Provider counts come from the federal NPPES registry and CMS Doctors and Clinicians files. Payment figures come from the CMS Open Payments program for calendar year 2025. The directory refreshes monthly.
All specialties Ask Zach for help choosing